Does co-morbidity index predict for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer?
The number and seriousness of co-morbidities predict overall survival in medically inoperable early-stage NSCLC treated with SBRT. Because the determination of medical operability is frequently based on both objective measures and subjective clinical judgment, it is recommended that co-morbidity be formally indexed in all studies examining the outcomes of SBRT.
MR imaging of the breast is not reliable in differentiation of benign from malignant breast disease in mammographically suspicious clustered microcalcifications and has no effect on treatment.